- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 403/10
Total number of patents in this class: 3145
10-year publication summary
|
229
|
219
|
243
|
252
|
247
|
186
|
220
|
234
|
164
|
106
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17632 |
134 |
| Merck Patent GmbH | 5831 |
127 |
| Samsung Display Co., Ltd. | 34696 |
80 |
| Bristol-myers Squibb Company | 4898 |
78 |
| Idemitsu Kosan Co., Ltd. | 4219 |
66 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
47 |
| Merck Sharp & Dohme LLC | 3748 |
35 |
| Novartis AG | 10849 |
34 |
| Samsung SDI Co., Ltd. | 8319 |
34 |
| F. Hoffmann-La Roche AG | 7925 |
32 |
| VALO Health, Inc. | 172 |
32 |
| Takeda Pharmaceutical Company Limited | 2713 |
31 |
| Duk San Neolux Co., Ltd. | 651 |
30 |
| LT Materials Co., Ltd. | 406 |
30 |
| Janssen Pharmaceutica N.V. | 3392 |
28 |
| Doosan Corporation | 434 |
28 |
| DuPont Specialty Materials Korea Ltd. | 287 |
28 |
| Boehringer Ingelheim International GmbH | 4650 |
27 |
| Abbvie Inc. | 1800 |
26 |
| AstraZeneca AB | 2909 |
25 |
| Other owners | 2193 |